In just 2 minutes Paul Krugman destroyed the biggest criticisms of EpiPen-maker Mylan

Paul Krugman stopped by Business Insider to talk to senior editor Josh Barro. Here Krugman explains the real issues behind the EpiPen price hike

Follow BI Video: On Twitter

Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.